Journal Information

Statistics

Follow this link to access the full text of the article

452
POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE AFTER 1 PRIOR LINE OF THERAPY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF OPTIMMISM BY AGE, PRIOR TRANSPLANT, AND HIGH-RISK CYTOGENETICS
M. Dimopoulosa, K. Weiselb, P. Moreauc, L.D.A. Jrd, D. Whitee, J.S. Miguelf, P. Sonneveldg, M. Engelhardth, M. Jenneri, A. Corsoj, J. Dürigk, M. Pavicl, M. Salomom, E. Casaln, R. Jiangn, T. Nguyenn, T. Pelusoo, P. Richardsonp
a National and Kapodistrian University of Athens, Athens, Greece
b Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
c University Hospital Hôtel-Dieu, Nantes, France
d UT Southwestern Medical Center, Dallas, United States
e Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Canada
f Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain
g Erasmus MC Cancer Institute, Rotterdam, the Netherlands
h Universitätsklinikum Freiburg, Freiburg, Germany
i Southampton General Hospital, Southampton, United Kingdom
j Division of Hematology, Hospital of Legnano, Legnano, Italy
k University Hospital Essen, Essen, Germany
l Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Centre de Recherche Clinique Etienne-Le Bel (CRCELB) Hopital Fleurimont, Sherbrooke, Canada
m Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
n Bristol Myers Squibb, Princeton, United States
o Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
p Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States
Ver más
Read
1908
Times
was read the article
953
Total PDF
955
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 10 9 19
2024 March 28 21 49
2024 February 18 23 41
2024 January 20 21 41
2023 December 23 24 47
2023 November 41 31 72
2023 October 17 29 46
2023 September 24 31 55
2023 August 14 15 29
2023 July 18 14 32
2023 June 29 17 46
2023 May 31 9 40
2023 April 13 9 22
2023 March 32 13 45
2023 February 18 15 33
2023 January 16 14 30
2022 December 29 21 50
2022 November 26 15 41
2022 October 21 21 42
2022 September 29 22 51
2022 August 26 20 46
2022 July 23 25 48
2022 June 20 22 42
2022 May 25 29 54
2022 April 16 20 36
2022 March 20 21 41
2022 February 14 28 42
2022 January 14 24 38
2021 December 16 22 38
2021 November 15 24 39
2021 October 34 38 72
2021 September 21 32 53
2021 August 29 24 53
2021 July 26 41 67
2021 June 17 28 45
2021 May 16 28 44
2021 April 52 53 105
2021 March 45 36 81
2021 February 19 13 32
2021 January 15 11 26
2020 December 17 25 42
2020 November 18 15 33
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy